Global Prostate Cancer Testing Market Research Report 2023

Report ID: 1988895 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prostate Cancer Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 PSA Tests
        1.2.3 CTC Tests
        1.2.4 Immunohistochemistry
        1.2.5 PCA3 Tests
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Prostate Cancer Testing Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Associated Labs
        1.3.3 Independent Diagnostic Laboratories
        1.3.4 Cancer Research Institutes
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Prostate Cancer Testing Market Perspective (2017-2028)
    2.2 Prostate Cancer Testing Growth Trends by Region
        2.2.1 Prostate Cancer Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Prostate Cancer Testing Historic Market Size by Region (2017-2022)
        2.2.3 Prostate Cancer Testing Forecasted Market Size by Region (2023-2028)
    2.3 Prostate Cancer Testing Market Dynamics
        2.3.1 Prostate Cancer Testing Industry Trends
        2.3.2 Prostate Cancer Testing Market Drivers
        2.3.3 Prostate Cancer Testing Market Challenges
        2.3.4 Prostate Cancer Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Prostate Cancer Testing Players by Revenue
        3.1.1 Global Top Prostate Cancer Testing Players by Revenue (2017-2022)
        3.1.2 Global Prostate Cancer Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Prostate Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Prostate Cancer Testing Revenue
    3.4 Global Prostate Cancer Testing Market Concentration Ratio
        3.4.1 Global Prostate Cancer Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Testing Revenue in 2021
    3.5 Prostate Cancer Testing Key Players Head office and Area Served
    3.6 Key Players Prostate Cancer Testing Product Solution and Service
    3.7 Date of Enter into Prostate Cancer Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Testing Breakdown Data by Type
    4.1 Global Prostate Cancer Testing Historic Market Size by Type (2017-2022)
    4.2 Global Prostate Cancer Testing Forecasted Market Size by Type (2023-2028)
5 Prostate Cancer Testing Breakdown Data by Application
    5.1 Global Prostate Cancer Testing Historic Market Size by Application (2017-2022)
    5.2 Global Prostate Cancer Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Prostate Cancer Testing Market Size (2017-2028)
    6.2 North America Prostate Cancer Testing Market Size by Country (2017-2022)
    6.3 North America Prostate Cancer Testing Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Prostate Cancer Testing Market Size (2017-2028)
    7.2 Europe Prostate Cancer Testing Market Size by Country (2017-2022)
    7.3 Europe Prostate Cancer Testing Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Prostate Cancer Testing Market Size (2017-2028)
    8.2 Asia-Pacific Prostate Cancer Testing Market Size by Country (2017-2022)
    8.3 Asia-Pacific Prostate Cancer Testing Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Prostate Cancer Testing Market Size (2017-2028)
    9.2 Latin America Prostate Cancer Testing Market Size by Country (2017-2022)
    9.3 Latin America Prostate Cancer Testing Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Prostate Cancer Testing Market Size (2017-2028)
    10.2 Middle East & Africa Prostate Cancer Testing Market Size by Country (2017-2022)
    10.3 Middle East & Africa Prostate Cancer Testing Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Genomic Health
        11.1.1 Genomic Health Company Detail
        11.1.2 Genomic Health Business Overview
        11.1.3 Genomic Health Prostate Cancer Testing Introduction
        11.1.4 Genomic Health Revenue in Prostate Cancer Testing Business (2017-2022)
        11.1.5 Genomic Health Recent Development
    11.2 OPKO
        11.2.1 OPKO Company Detail
        11.2.2 OPKO Business Overview
        11.2.3 OPKO Prostate Cancer Testing Introduction
        11.2.4 OPKO Revenue in Prostate Cancer Testing Business (2017-2022)
        11.2.5 OPKO Recent Development
    11.3 Siemens Healthcare
        11.3.1 Siemens Healthcare Company Detail
        11.3.2 Siemens Healthcare Business Overview
        11.3.3 Siemens Healthcare Prostate Cancer Testing Introduction
        11.3.4 Siemens Healthcare Revenue in Prostate Cancer Testing Business (2017-2022)
        11.3.5 Siemens Healthcare Recent Development
    11.4 DiaSorin
        11.4.1 DiaSorin Company Detail
        11.4.2 DiaSorin Business Overview
        11.4.3 DiaSorin Prostate Cancer Testing Introduction
        11.4.4 DiaSorin Revenue in Prostate Cancer Testing Business (2017-2022)
        11.4.5 DiaSorin Recent Development
    11.5 bioMeriux
        11.5.1 bioMeriux Company Detail
        11.5.2 bioMeriux Business Overview
        11.5.3 bioMeriux Prostate Cancer Testing Introduction
        11.5.4 bioMeriux Revenue in Prostate Cancer Testing Business (2017-2022)
        11.5.5 bioMeriux Recent Development
    11.6 Roche
        11.6.1 Roche Company Detail
        11.6.2 Roche Business Overview
        11.6.3 Roche Prostate Cancer Testing Introduction
        11.6.4 Roche Revenue in Prostate Cancer Testing Business (2017-2022)
        11.6.5 Roche Recent Development
    11.7 MDx Health
        11.7.1 MDx Health Company Detail
        11.7.2 MDx Health Business Overview
        11.7.3 MDx Health Prostate Cancer Testing Introduction
        11.7.4 MDx Health Revenue in Prostate Cancer Testing Business (2017-2022)
        11.7.5 MDx Health Recent Development
    11.8 Beckman Coulter
        11.8.1 Beckman Coulter Company Detail
        11.8.2 Beckman Coulter Business Overview
        11.8.3 Beckman Coulter Prostate Cancer Testing Introduction
        11.8.4 Beckman Coulter Revenue in Prostate Cancer Testing Business (2017-2022)
        11.8.5 Beckman Coulter Recent Development
    11.9 Myriad Genetics
        11.9.1 Myriad Genetics Company Detail
        11.9.2 Myriad Genetics Business Overview
        11.9.3 Myriad Genetics Prostate Cancer Testing Introduction
        11.9.4 Myriad Genetics Revenue in Prostate Cancer Testing Business (2017-2022)
        11.9.5 Myriad Genetics Recent Development
    11.10 Ambry Genetics
        11.10.1 Ambry Genetics Company Detail
        11.10.2 Ambry Genetics Business Overview
        11.10.3 Ambry Genetics Prostate Cancer Testing Introduction
        11.10.4 Ambry Genetics Revenue in Prostate Cancer Testing Business (2017-2022)
        11.10.5 Ambry Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Prostate Cancer Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of PSA Tests
    Table 3. Key Players of CTC Tests
    Table 4. Key Players of Immunohistochemistry
    Table 5. Key Players of PCA3 Tests
    Table 6. Key Players of Others
    Table 7. Global Prostate Cancer Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Prostate Cancer Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Prostate Cancer Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Prostate Cancer Testing Market Share by Region (2017-2022)
    Table 11. Global Prostate Cancer Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Prostate Cancer Testing Market Share by Region (2023-2028)
    Table 13. Prostate Cancer Testing Market Trends
    Table 14. Prostate Cancer Testing Market Drivers
    Table 15. Prostate Cancer Testing Market Challenges
    Table 16. Prostate Cancer Testing Market Restraints
    Table 17. Global Prostate Cancer Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Prostate Cancer Testing Market Share by Players (2017-2022)
    Table 19. Global Top Prostate Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Testing as of 2021)
    Table 20. Ranking of Global Top Prostate Cancer Testing Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Prostate Cancer Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Prostate Cancer Testing Product Solution and Service
    Table 24. Date of Enter into Prostate Cancer Testing Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Prostate Cancer Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Prostate Cancer Testing Revenue Market Share by Type (2017-2022)
    Table 28. Global Prostate Cancer Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Prostate Cancer Testing Revenue Market Share by Type (2023-2028)
    Table 30. Global Prostate Cancer Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Prostate Cancer Testing Revenue Market Share by Application (2017-2022)
    Table 32. Global Prostate Cancer Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Prostate Cancer Testing Revenue Market Share by Application (2023-2028)
    Table 34. North America Prostate Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Prostate Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Prostate Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Prostate Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Prostate Cancer Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Prostate Cancer Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Prostate Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Prostate Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Prostate Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Prostate Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Genomic Health Company Detail
    Table 45. Genomic Health Business Overview
    Table 46. Genomic Health Prostate Cancer Testing Product
    Table 47. Genomic Health Revenue in Prostate Cancer Testing Business (2017-2022) & (US$ Million)
    Table 48. Genomic Health Recent Development
    Table 49. OPKO Company Detail
    Table 50. OPKO Business Overview
    Table 51. OPKO Prostate Cancer Testing Product
    Table 52. OPKO Revenue in Prostate Cancer Testing Business (2017-2022) & (US$ Million)
    Table 53. OPKO Recent Development
    Table 54. Siemens Healthcare Company Detail
    Table 55. Siemens Healthcare Business Overview
    Table 56. Siemens Healthcare Prostate Cancer Testing Product
    Table 57. Siemens Healthcare Revenue in Prostate Cancer Testing Business (2017-2022) & (US$ Million)
    Table 58. Siemens Healthcare Recent Development
    Table 59. DiaSorin Company Detail
    Table 60. DiaSorin Business Overview
    Table 61. DiaSorin Prostate Cancer Testing Product
    Table 62. DiaSorin Revenue in Prostate Cancer Testing Business (2017-2022) & (US$ Million)
    Table 63. DiaSorin Recent Development
    Table 64. bioMeriux Company Detail
    Table 65. bioMeriux Business Overview
    Table 66. bioMeriux Prostate Cancer Testing Product
    Table 67. bioMeriux Revenue in Prostate Cancer Testing Business (2017-2022) & (US$ Million)
    Table 68. bioMeriux Recent Development
    Table 69. Roche Company Detail
    Table 70. Roche Business Overview
    Table 71. Roche Prostate Cancer Testing Product
    Table 72. Roche Revenue in Prostate Cancer Testing Business (2017-2022) & (US$ Million)
    Table 73. Roche Recent Development
    Table 74. MDx Health Company Detail
    Table 75. MDx Health Business Overview
    Table 76. MDx Health Prostate Cancer Testing Product
    Table 77. MDx Health Revenue in Prostate Cancer Testing Business (2017-2022) & (US$ Million)
    Table 78. MDx Health Recent Development
    Table 79. Beckman Coulter Company Detail
    Table 80. Beckman Coulter Business Overview
    Table 81. Beckman Coulter Prostate Cancer Testing Product
    Table 82. Beckman Coulter Revenue in Prostate Cancer Testing Business (2017-2022) & (US$ Million)
    Table 83. Beckman Coulter Recent Development
    Table 84. Myriad Genetics Company Detail
    Table 85. Myriad Genetics Business Overview
    Table 86. Myriad Genetics Prostate Cancer Testing Product
    Table 87. Myriad Genetics Revenue in Prostate Cancer Testing Business (2017-2022) & (US$ Million)
    Table 88. Myriad Genetics Recent Development
    Table 89. Ambry Genetics Company Detail
    Table 90. Ambry Genetics Business Overview
    Table 91. Ambry Genetics Prostate Cancer Testing Product
    Table 92. Ambry Genetics Revenue in Prostate Cancer Testing Business (2017-2022) & (US$ Million)
    Table 93. Ambry Genetics Recent Development
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate Cancer Testing Market Share by Type: 2021 VS 2028
    Figure 2. PSA Tests Features
    Figure 3. CTC Tests Features
    Figure 4. Immunohistochemistry Features
    Figure 5. PCA3 Tests Features
    Figure 6. Others Features
    Figure 7. Global Prostate Cancer Testing Market Share by Application in 2021 & 2028
    Figure 8. Hospital Associated Labs Case Studies
    Figure 9. Independent Diagnostic Laboratories Case Studies
    Figure 10. Cancer Research Institutes Case Studies
    Figure 11. Others Case Studies
    Figure 12. Prostate Cancer Testing Report Years Considered
    Figure 13. Global Prostate Cancer Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Prostate Cancer Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Prostate Cancer Testing Market Share by Region: 2021 VS 2028
    Figure 16. Global Prostate Cancer Testing Market Share by Players in 2021
    Figure 17. Global Top Prostate Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Testing as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Prostate Cancer Testing Revenue in 2021
    Figure 19. North America Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Prostate Cancer Testing Market Share by Country (2017-2028)
    Figure 21. United States Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Prostate Cancer Testing Market Share by Country (2017-2028)
    Figure 25. Germany Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Prostate Cancer Testing Market Share by Region (2017-2028)
    Figure 33. China Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Prostate Cancer Testing Market Share by Country (2017-2028)
    Figure 41. Mexico Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Prostate Cancer Testing Market Share by Country (2017-2028)
    Figure 45. Turkey Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Prostate Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Genomic Health Revenue Growth Rate in Prostate Cancer Testing Business (2017-2022)
    Figure 48. OPKO Revenue Growth Rate in Prostate Cancer Testing Business (2017-2022)
    Figure 49. Siemens Healthcare Revenue Growth Rate in Prostate Cancer Testing Business (2017-2022)
    Figure 50. DiaSorin Revenue Growth Rate in Prostate Cancer Testing Business (2017-2022)
    Figure 51. bioMeriux Revenue Growth Rate in Prostate Cancer Testing Business (2017-2022)
    Figure 52. Roche Revenue Growth Rate in Prostate Cancer Testing Business (2017-2022)
    Figure 53. MDx Health Revenue Growth Rate in Prostate Cancer Testing Business (2017-2022)
    Figure 54. Beckman Coulter Revenue Growth Rate in Prostate Cancer Testing Business (2017-2022)
    Figure 55. Myriad Genetics Revenue Growth Rate in Prostate Cancer Testing Business (2017-2022)
    Figure 56. Ambry Genetics Revenue Growth Rate in Prostate Cancer Testing Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Genomic Health
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
Frequently Asked Questions
Prostate Cancer Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prostate Cancer Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prostate Cancer Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Gel Electrophoresis

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More